PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportscoronary artery disease
MeSH D003324 - coronary artery disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001161:Arteriosclerosis
5 Companies
1 Drug
$
Success rate
D003327:Coronary disease
50 Companies
8 Drugs
$
Success rate
D003324: 
Coronary artery disease
111 Companies
31 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsFenofibrate Fenoglide 2024-10-01 2007-08-10   
TevaAmlodipine besylate Amlodipine Besylate  2007-06-28   
Benazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2007-05-18   
Valsartan, Amlodipine besylate Amlodipine Besylate Valsartan  2015-03-30   
Hydrochlorothiazide, Valsartan, Amlodipine besylate Amlodipine Besylate, Valsartan Hydrochlorothiazide  2012-09-25   
Olmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2016-10-26   
Atorvastatin Atorvastatin  2012-05-29   
Fluvastatin Fluvastatin  2012-06-12   
Gemfibrozil Gemfibrozil  1993-10-31   
Lovastatin Lovastatin  2001-12-17   
Hydrochlorothiazide, Olmesartan medoxomil, Amlodipine besylate Olmesartan Medoxomil, Amlodipine Hydrochlorothiazide  2016-11-03   
Rosuvastatin Rosuvastatin  2016-07-19   
Simvastatin Simvastatin  2006-06-23   
Aurobindo PharmaPravastatin Pravastatin  2006-04-24   
Amlodipine besylate Amlodipine Besylate  2007-07-17   
Benazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2012-09-05   
Valsartan, Amlodipine besylate Amlodipine Besylate Valsartan  2016-04-22   
Hydrochlorothiazide, Valsartan, Amlodipine besylate Amlodipine Besylate, Valsartan Hydrochlorothiazide  2017-12-19   
Olmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2017-05-15   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2020-12-17   
Fenofibrate Fenofibrate  2016-05-05   
Gemfibrozil Gemfibrozil  2015-09-16   
Rosuvastatin Rosuvastatin  2016-07-19   
Simvastatin Simvastatin  2006-12-20   
Lovastatin Lovastatin  2001-12-17   
Atorvastatin Atorvastatin  2024-02-13   
Novast LaboratoriesFenofibrate Fenofibrate  2019-04-19   
Glenmark PharmaceuticalsOlmesartan medoxomil, Amlodipine besylate Amlodipine Olmesartan Medoxomil  2017-07-05   
Colesevelam Colesevelam  2018-07-16   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2019-06-27   
Fenofibrate Fenofibrate  2017-04-07   
Pravastatin Pravastatin  2007-05-11   
Rosuvastatin Rosuvastatin  2016-07-19   
MylanAmlodipine, Valsartan Amlodipine / Valsartan Mylan  2016-03-22   
Amlodipine besylate Amlodipine Besylate  2005-10-03   
Atorvastatin, Amlodipine besylate Amlodipine Besylate Atorvastatin  2013-11-29   
Benazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2011-07-05   
Valsartan, Amlodipine besylate Amlodipine Besylate Valsartan  2015-03-30   
Atorvastatin Atorvastatin  2012-05-29   
Fenofibrate Fenofibrate  2005-12-29   
Fluvastatin Fluvastatin  2012-04-11   
Gemfibrozil Gemfibrozil  1995-02-16   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2010-06-08   
Telmisartan, Amlodipine besylate Telmisartan Amlodipine  2014-08-26   
Rivaroxaban Rivaroxaban Viatris (previously Rivaroxaban Mylan)  2021-11-12   
Rising PharmaceuticalsBenazepril, Amlodipine besylate Amlodipine Besylate Benazepril  2010-05-21   
Simvastatin Simvastatin  2006-12-20   
Fenofibrate Fenofibrate  2012-10-23   
NATCO PharmaGemfibrozil Gemfibrozil  1993-01-25   
PerrigoAtorvastatin Atorvastatin  2020-06-23   
CiplaAmlodipine besylate Amlodipine Besylate  2007-09-26   
Atorvastatin Atorvastatin  2017-01-09   
Colesevelam Colesevelam  2020-04-20   
Fenofibrate Fenofibrate  2017-03-28   
Gemfibrozil Gemfibrozil  2006-07-27   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2017-11-13   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
71%
34/48
Phase 2
71%
62/87
Phase 3
59%
74/125
Approved: 18Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
3M
Chlorhexidine,
Chlorhexidine gluconate
AbbVie
Bevifimod
Allergan
Amlodipine besylate
AstraZeneca
Rosuvastatin,
Salicylic acid,
Benzocaine,
Fluorodopa f-18,
Aglatimagene besadenovec,
Maxacalcitol,
Bevifimod,
Nepidermin,
Riboprine,
Fludeoxyglucose f-18,
Antineoplaston a10,
Histone-arginine methyltransferase carm1,
Curcumin,
P2y purinoceptor 12,
Surlorian,
Thienopyridine
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use